Atlas Trials

Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin)

Clinical trial NCT00505648 · TERMINATED

Trial details

NCT number
NCT00505648
Sponsor
University Hospital, Rouen
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Drug Hypersensitivity
Start date
2008-01-01
Primary completion
2010-06-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.